Next Article in Journal
Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study
Previous Article in Journal
An Interrupted Time Series Analysis of the Impact of the COVID-19 Pandemic on Routine Vaccination Uptake in Kenya
 
 
vaccines-logo
Article Menu

Article Menu

Article

Article Versions Notes

Vaccines 2024, 12(8), 825; https://doi.org/10.3390/vaccines12080825
Action Date Notes Link
article xml file uploaded 23 July 2024 08:20 CEST Original file -
article xml uploaded. 23 July 2024 08:20 CEST Update -
article pdf uploaded. 23 July 2024 08:20 CEST Version of Record -
article supplementary file uploaded. 23 July 2024 08:20 CEST - https://www.mdpi.com/2076-393X/12/8/825#supplementary
article html file updated 23 July 2024 08:21 CEST Original file -
article xml file uploaded 23 July 2024 10:51 CEST Update -
article xml uploaded. 23 July 2024 10:51 CEST Update https://www.mdpi.com/2076-393X/12/8/825/xml
article pdf uploaded. 23 July 2024 10:51 CEST Updated version of record https://www.mdpi.com/2076-393X/12/8/825/pdf
article html file updated 23 July 2024 10:53 CEST Update https://www.mdpi.com/2076-393X/12/8/825/html
Back to TopTop